Patents by Inventor Jianhua Cao
Jianhua Cao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20110317022Abstract: A live image transferring method includes the steps of capturing live image information by one or more live image devices, wherein the live image information is captured in raw format and is continuously transferred to one or more platforms in a live manner; cloning the live image information at the platform, wherein when the live image information is cloned at the platform, the live image information is converted from the raw format into a web viewable format and an embed code is generated corresponding to the live image information at the same time; and enabling one or more users to use the embed code in order to broadcast the live image information over any website. The user is able to copy-and-paste the embed code at the personal website to live stream the live image information from the live image device.Type: ApplicationFiled: September 2, 2011Publication date: December 29, 2011Inventor: Jianhua Cao
-
Publication number: 20110308934Abstract: A method for producing cellulose diacetate with bamboo fibers as a raw material having the steps of soaking, treating with ultrasonic sound, de-acidifying, acetylating, hydrolyzing, precipitating, screening, extruding, washing, rolling, and drying. The method reduces the material loss and pollution, completely swells and dissolves the bamboo fibers, accelerates the fibrillation, reduces the crystallinity, improves the accessibility of the fibers, recycles acetic acid, and reduces the material consumption.Type: ApplicationFiled: October 18, 2010Publication date: December 22, 2011Inventors: Zhanping YANG, Xiaolong MA, Xiaodong LI, Jianhua CAO, Chunhong GAO
-
Publication number: 20110224136Abstract: The present invention relates to novel heterocyclic compounds as diacylglycerol acyltransferase (“DGAT”) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the invention is shown below.Type: ApplicationFiled: November 17, 2009Publication date: September 15, 2011Inventors: Pauline C. Ting, Robert Aslanian, Mary Ann Caplen, Jianhua Cao, David Kim, Hyunjin Kim, Rongze Kuang, Joe F. Lee, John Schwerdt, Heping Wu, Gang Zhou, Nicolas Zorn
-
Publication number: 20110224137Abstract: The present invention relates to novel heterocyclic compounds as diacylglycerol acyltransferase (“DGAT”) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the invention is shown below: formula (I).Type: ApplicationFiled: November 17, 2009Publication date: September 15, 2011Inventors: Pauline C. Ting, Robert Aslanian, Mary Ann Caplen, Jianhua Cao, Tin-Yau Chan, David Kim, Hyunjin Kim, Jae-Hun Kim, Rongze Kuang, Joe F. Lee, John Schwerdt, Heping Wu, Nicolas Zorn
-
Publication number: 20110224193Abstract: The present invention relates to novel heterocyclic compounds as diacylglycerol acyltransferase (“DGAT”) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the invention is shown with this abstract.Type: ApplicationFiled: November 17, 2009Publication date: September 15, 2011Inventors: Pauline C. Ting, Robert Aslanian, Jianhua Cao, Mary Ann Caplen, Tin-Yau Chan, Hyunjin Kim, Jae-Hun Kim, Rongze Kuang, Joe F. Lee, Heping Wu
-
Publication number: 20110037864Abstract: A live image system for transferring live images via Internet includes one or more live image providers adapted for frequently capturing live image information with a predetermined capture interval, and a platform communicatively linking with the live image providers through Internet. The live image information, which is a still image file and a web based viewable format, is continuously transferred to the platform. Therefore when the live image information is kept refreshing at the platform by overwriting the previous live image information with the latest live image information, the platform provides a real time video like image at a predetermined frame rate for web browsers to watch without any proprietary software.Type: ApplicationFiled: August 17, 2009Publication date: February 17, 2011Inventor: Jianhua Cao
-
Patent number: 7705153Abstract: The use of CCR3 antagonists of the formula I or a pharmaceutically acceptable salt thereof for the treatment of asthma is disclosed, as well as novel compounds of the formula II, pharmaceutical compositions comprising them, and their use in the treatment of asthma, wherein R, Ra, X, Xa, R1, R2, R2a, R14, R14a, R16 and n are as defined in the specification.Type: GrantFiled: February 2, 2005Date of Patent: April 27, 2010Assignee: Schering CorporationInventors: Pauline C. Ting, Jianhua Cao, Youhao Dong, Eric J. Gilbert, Ying Huang, Joseph M. Kelly, Stuart McCombie, Neng-Yang Shih
-
Publication number: 20090170861Abstract: In its many embodiments, the present invention provides -substituted pyridazinone compounds as glucan synthase inhibitors, methods of preparing such compounds, pharmaceutical including one or more of such compounds, methods of preparing pharmaceutical formulations including one or more such compounds or one or more such compounds along with other antifungal agents, and methods of treatment, prevention, inhibition, or amelioration of one or more fungal infections associated with glucan synthase using such compounds or pharmaceutical compositions.Type: ApplicationFiled: March 12, 2008Publication date: July 2, 2009Inventors: Pauline C. Ting, Robert G. Aslanian, Jianhua Cao, David Won-Shik Kim, Rongze Kuang, Gang Zhou, Robert Jason Herr, Andrew John Zych, Jinhai Yang, Heping Wu, Nicolas Zorn
-
Patent number: 7511062Abstract: The invention claims compounds of the formula wherein is a 5-membered heteroaryl; X is S or O; R1 is H, alkyl, cycloalkyl, cylcoalkylalkyl-, —CH2F, —CHF2, —CF3, —C(O)alkyl or —C(O)NR18R19; R3 and R4 H, alkyl, hydroxyalkyl or —C(O)Oalkyl; R5 and R6 are H, alkyl, hydroxyalkyl, alkoxyalkyl, mercaptoalkyl, —CH2F, —CHF2, —CF3, —C(O)OH or —C(O)Oalkyl; R7 is H, alkyl, alkenyl, hydroxyalkyl, cycloalkyl, alkoxyalkyl, aminoalkyl, (R17-phenyl)alkyl or —CH2—C(O)—O-alkyl; and R8 comprises alkyl, heteroaryl, phenyl or cycloalkyl, or heterocycloalkyl, all optionally substituted, or a cycloalkyl- or heterocycloalkyl-substituted amide; or R7 and R8 and the nitrogen to which they are attached together form an optionally substituted ring; and the remaining variables are as defined in the specification. Also claimed are pharmaceutical compositions, the use of the compounds as PDE4 inhibitors, and combinations with other actives.Type: GrantFiled: May 16, 2005Date of Patent: March 31, 2009Assignee: Schering CorporationInventors: Rongze Kuang, David Blythin, Neng-Yang Shih, Ho-Jane Shue, Xiao Chen, Jianhua Cao, Danlin Gu, Ying Huang, John H. Schwerdt, Pauline C. Ting, Shing-Chun Wong, Li Xiao
-
Patent number: 7238688Abstract: Disclosed are novel compounds of the formula Also disclosed are pharmaceutical compositions comprising the compounds of Formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula I in combination with a H1 receptor antagonist.Type: GrantFiled: October 27, 2004Date of Patent: July 3, 2007Assignee: Schering CorporationInventors: Stuart B. Rosenblum, Qingbei Zeng, Mwangi Wa Mutahi, Robert G. Aslanian, Pauline C. Ting, Neng-Yang Shih, Daniel M. Solomon, Jianhua Cao, Henry A. Vaccaro, Kevin D. McCormick, John J. Baldwin, Ge Li
-
Patent number: 7220735Abstract: Disclosed are novel compounds of the formula wherein R1 is benzimidazolone derivative, M1 and M2 are optionally substituted carbon or nitrogen, R2 includes optionally substituted aryl or heteroaryl, and the remaining variables are as defined in the specification, and the remaining variables are as defined in the specification; also disclosed are pharmaceutical compositions comprising the compounds of formula I and methods of treating various diseases or conditions, such as allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of formula I, as well as methods of treating said diseases or conditions using the compounds of formula I in combination with an H1 receptor antagonist.Type: GrantFiled: April 16, 2003Date of Patent: May 22, 2007Assignee: Schering CorporationInventors: Pauline C. Ting, Robert G. Aslanian, Michael Y. Berlin, Christopher W. Boyce, Jianhua Cao, Pietro Mangiaracina, Kevin D. McCormick, Mwangi W. Mutahi, Stuart B. Rosenblum, Neng-Yang Shih, Daniel M. Solomon, Wing C. Tom, Qingbei Zeng
-
Patent number: 7105505Abstract: Disclosed are novel compounds of the formula wherein R1 is optionally substituted benzimidazolyl or a derivative thereof; R2 is optionally substituted aryl or heteroaryl; M1 and M2 are C(R3) or N; and the remaining variables are as defined in the specification; also disclosed are pharmaceutical compositions comprising the compounds of formula I and methods of treating various diseases or conditions, such as allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of formula I, as well as methods of treating said diseases or conditions using the compounds of formula I in combination with an H1 receptor antagonist.Type: GrantFiled: April 16, 2003Date of Patent: September 12, 2006Assignee: Schering CorporationInventors: Qingbei Zeng, Robert G. Aslanian, Michael Y. Berlin, Christopher W. Boyce, Jianhua Cao, Joseph A. Kozlowski, Pietro Mangiaracina, Kevin D. McCormick, Mwangi W. Mutahi, Stuart B. Rosenblum, Neng-Yang Shih, Daniel M. Solomon, Wing C. Tom
-
Publication number: 20060106062Abstract: The invention claims compounds of the formula wherein is a 5-membered heteroaryl; X is S or O; R1 is H, alkyl, cycloalkyl, cylcoalkylalkyl-, —CH2F, —CHF2, —CF3, —C(O)alkyl or —C(O)NR18R19; R3 and R4H, alkyl, hydroxyalkyl or —C(O)Oalkyl; R5 and R6 are H, alkyl, hydroxyalkyl, alkoxyalkyl, mercaptoalkyl, —CH2F, —CHF2, —CF3, —C(O)OH or —C(O)Oalkyl; R7 is H, alkyl, alkenyl, hydroxyalkyl, cycloalkyl, alkoxyalkyl, aminoalkyl, (R17-phenyl)alkyl or —CH2—C(O)—O-alkyl; and R8 comprises alkyl, heteroaryl, phenyl or cycloalkyl, or heterocycloalkyl, all optionally substituted, or a cycloalkyl- or heterocycloalkyl-substituted amide; or R7 and R8 and the nitrogen to which they are attached together form an optionally substituted ring; and the remaining variables are as defined in the specification. Also claimed are pharmaceutical compositions, the use of the compounds as PDE4 inhibitors, and combinations with other actives.Type: ApplicationFiled: May 16, 2005Publication date: May 18, 2006Inventors: Rongze Kuang, David Blythin, Neng-Yang Shih, Ho-Jane Shue, Xiao Chen, Jianhua Cao, Danlin Gu, Ying Huang, John Schwerdt, Pauline Ting, Shing-Chun Wong, Li Xiao
-
Publication number: 20050182095Abstract: The use of CCR3 antagonists of the formula I or a pharmaceutically acceptable salt thereof for the treatment of asthma is disclosed, as well as novel compounds of the formula II, pharmaceutical compositions comprising them, and their use in the treatment of asthma, wherein R, Ra, X, Xa, R1, R2, R2a, R14, R14a, R16 and n are as defined in the specification.Type: ApplicationFiled: February 2, 2005Publication date: August 18, 2005Inventors: Pauline Ting, Jianhua Cao, Youhao Dong, Eric Gilbert, Ying Huang, Joseph Kelly, Stuart McCombie, Neng-Yang Shih
-
Publication number: 20050113383Abstract: Disclosed are novel compounds of the formula Also disclosed are pharmaceutical compositions comprising the compounds of Formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula I in combination with a H1 receptor antagonist.Type: ApplicationFiled: October 27, 2004Publication date: May 26, 2005Inventors: Stuart Rosenblum, Qingbei Zeng, Mwangi Mutahi, Robert Aslanian, Pauline Ting, Neng-Yang Shih, Daniel Solomon, Jianhua Cao, Henry Vaccaro, Kevin McCormick, John Baldwin, Ge Li
-
Patent number: 6849621Abstract: Disclosed are novel compounds of the formula Also disclosed are pharmaceutical compositions comprising the compounds of Formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula I in combination with a H. receptor antagonist.Type: GrantFiled: March 11, 2002Date of Patent: February 1, 2005Assignees: Schering Corporation, Pharmacopeia Drug Discovery, Inc.Inventors: Stuart B. Rosenblum, Qingbei Zeng, Mwangi Wa Mutahi, Robert G. Aslanian, Pauline C. Ting, Neng-Yang Shih, Daniel M. Solomon, Jianhua Cao, Henry A. Vaccaro, Kevin D. McCormick, John J. Baldwin, Ge Li
-
Publication number: 20040097483Abstract: Disclosed are novel compounds of the formula 1Type: ApplicationFiled: April 16, 2003Publication date: May 20, 2004Inventors: Qingbei Zeng, Robert G. Aslanian, Michael Y. Berlin, Christopher W. Boyce, Jianhua Cao, Joseph A. Kozlowski, Pietro Mangiaracina, Kevin D. McCormick, Mwangi W. Mutahi, Stuart B. Rosenblum, Neng-Yang Shih, Daniel M. Solomon, Wing C. Tom
-
Publication number: 20040048843Abstract: Disclosed are novel compounds of the formula 1Type: ApplicationFiled: April 16, 2003Publication date: March 11, 2004Applicant: Schering CorporationInventors: Pauline C. Ting, Robert G. Aslanian, Michael Y. Berlin, Christopher W. Boyce, Jianhua Cao, Pietro Mangiaracina, Kevin D. McCormick, Mwangi W. Mutahi, Stuart B. Rosenblum, Neng-Yang Shih, Daniel M. Solomon, Wing C. Tom, Qingbei Zeng
-
Publication number: 20030109564Abstract: Disclosed are novel compounds of the formula 1Type: ApplicationFiled: March 11, 2002Publication date: June 12, 2003Applicant: Schering CorporationInventors: Stuart B. Rosenblum, Qingbei Zeng, Mwangi Wa Mutahi, Robert G. Aslanian, Pauline C. Ting, Neng-Yang Shih, Daniel M. Solomon, Jianhua Cao, Henry A. Vaccaro, Kevin D. McCormick, John J. Baldwin, Ge Li